The Lancet Psychiatry:应对策略疗法显著改善老年痴呆症护理人员精神健康与生活质量

2014-11-20 马宏伟 译 医学论坛网

发表在《柳叶刀精神病学》杂志的一项研究发现,便捷的应对策略疗法在无额外开销的标准护理中,可为对老年痴呆症家庭护理者提供减轻沮丧感并提高幸福感的作用。 该研究由英国伦敦大学学院老年人精神学研究部门吉尔利文斯顿教授发起,他发现接受START(STrAtegies 针对 RelaTives)项目的家庭护理者可显著减轻其忧郁程度,获益时间至少持续两年。而未接受项目治疗的人,其进展为临床显著忧郁症的概率高

发表在《柳叶刀精神病学》杂志的一项研究发现,便捷的应对策略疗法在无额外开销的标准护理中,可为对老年痴呆症家庭护理者提供减轻沮丧感并提高幸福感的作用。

该研究由英国伦敦大学学院老年人精神学研究部门吉尔利文斯顿教授发起,他发现接受START(STrAtegies 针对 RelaTives)项目的家庭护理者可显著减轻其忧郁程度,获益时间至少持续两年。而未接受项目治疗的人,其进展为临床显著忧郁症的概率高7倍。

三分之二的老年痴呆患者在家居住,接受家庭成员提供的护理。在英国大约有67万这样的家庭护理着,美国有超过1500万人口的家庭护理者。然而,约40%的家庭成员护理者最终进展为临床抑郁症或焦虑,这些可导致护理的终结,促使老年痴呆症患者被送入疗养院。

Livingston和他的同事们将260位家庭护理着随机分配,这些人在研究之初无忧郁症疾患,在试验中173人接受8疗程的 START项目治疗,87人接受常规项目治疗(包括针对忧郁症的医学、精神、社会服务)。

使用医学焦虑忧郁量表(HADS)对这些受试者进行评估,成本效益在两年以上。

平均来讲,将START组的家庭护理者与普通组相比,在短期(8个月)和长期(24个月)两个时间点进行比较后发现,前者的HADS总分(2.58分)显著提高。不仅如此,START的花费未超过常规护理的价格,说明其费效比可达最佳值。

根据Livingston教授的说法,在全球范围内有440万人口受到忧郁症困扰,而这一数据还以每二十年为周期的速度翻番增加。大多数人都会忽视与老年痴呆症相关的抑郁症患者对家庭成员护理所起到的显著作用。政策导向认为家庭成员将成为主要支持者。该新兴项目是一种有效的方法,能够支持护理者,并提高他们的精神健康和生活品质,这一方法值得全球化推广。

来自英国苏塞克斯布莱顿大学的抑郁症学研究的Sube Banerjee教授评论道,“ATART介入项目应作为个体化疗法提供给所有的老年痴呆症家庭护理者,并作为支持即时诊断的一部分。START项目应当成为老年痴呆症诊断服务中一项组成部分(诸如记忆恢复服务),并得到英国的临床调试组的委任。”

原始出处

Prof Gill Livingston MD a g , Julie Barber PhD b, Penny Rapaport DClinPsych a, Prof Martin Knapp PhD c, Mark Griffin MSc b, Derek King PhD c, Renee Romeo PhD d, Debbie Livingston MChS a, Cath Mummery ,etc.Long-term clinical and cost-effectiveness of psychological intervention for family carers of people with dementia: a single-blind, randomised, controlled trial.The Lancet Psychiatry, Early Online Publication, 19 November 2014

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1791896, encodeId=71621e91896e6, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Mar 26 10:52:00 CST 2015, time=2015-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1985826, encodeId=19cf1985826e8, content=<a href='/topic/show?id=d3de559667c' target=_blank style='color:#2F92EE;'>#护理人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55966, encryptionId=d3de559667c, topicName=护理人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Jun 26 10:52:00 CST 2015, time=2015-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26972, encodeId=97d4269e2d1, content=mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=761999770, createdName=wingjoy2009, createdTime=Thu Jun 11 07:41:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827931, encodeId=da82182e9313c, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Apr 17 07:52:00 CST 2015, time=2015-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1836091, encodeId=c28e1836091b9, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Tue Jan 06 11:52:00 CST 2015, time=2015-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992243, encodeId=8390199224388, content=<a href='/topic/show?id=7e5a492636a' target=_blank style='color:#2F92EE;'>#应对策略#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49263, encryptionId=7e5a492636a, topicName=应对策略)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Tue Feb 10 17:52:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1791896, encodeId=71621e91896e6, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Mar 26 10:52:00 CST 2015, time=2015-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1985826, encodeId=19cf1985826e8, content=<a href='/topic/show?id=d3de559667c' target=_blank style='color:#2F92EE;'>#护理人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55966, encryptionId=d3de559667c, topicName=护理人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Jun 26 10:52:00 CST 2015, time=2015-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26972, encodeId=97d4269e2d1, content=mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=761999770, createdName=wingjoy2009, createdTime=Thu Jun 11 07:41:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827931, encodeId=da82182e9313c, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Apr 17 07:52:00 CST 2015, time=2015-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1836091, encodeId=c28e1836091b9, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Tue Jan 06 11:52:00 CST 2015, time=2015-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992243, encodeId=8390199224388, content=<a href='/topic/show?id=7e5a492636a' target=_blank style='color:#2F92EE;'>#应对策略#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49263, encryptionId=7e5a492636a, topicName=应对策略)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Tue Feb 10 17:52:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1791896, encodeId=71621e91896e6, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Mar 26 10:52:00 CST 2015, time=2015-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1985826, encodeId=19cf1985826e8, content=<a href='/topic/show?id=d3de559667c' target=_blank style='color:#2F92EE;'>#护理人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55966, encryptionId=d3de559667c, topicName=护理人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Jun 26 10:52:00 CST 2015, time=2015-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26972, encodeId=97d4269e2d1, content=mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=761999770, createdName=wingjoy2009, createdTime=Thu Jun 11 07:41:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827931, encodeId=da82182e9313c, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Apr 17 07:52:00 CST 2015, time=2015-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1836091, encodeId=c28e1836091b9, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Tue Jan 06 11:52:00 CST 2015, time=2015-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992243, encodeId=8390199224388, content=<a href='/topic/show?id=7e5a492636a' target=_blank style='color:#2F92EE;'>#应对策略#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49263, encryptionId=7e5a492636a, topicName=应对策略)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Tue Feb 10 17:52:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]
    2015-06-11 wingjoy2009

    mark

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1791896, encodeId=71621e91896e6, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Mar 26 10:52:00 CST 2015, time=2015-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1985826, encodeId=19cf1985826e8, content=<a href='/topic/show?id=d3de559667c' target=_blank style='color:#2F92EE;'>#护理人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55966, encryptionId=d3de559667c, topicName=护理人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Jun 26 10:52:00 CST 2015, time=2015-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26972, encodeId=97d4269e2d1, content=mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=761999770, createdName=wingjoy2009, createdTime=Thu Jun 11 07:41:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827931, encodeId=da82182e9313c, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Apr 17 07:52:00 CST 2015, time=2015-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1836091, encodeId=c28e1836091b9, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Tue Jan 06 11:52:00 CST 2015, time=2015-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992243, encodeId=8390199224388, content=<a href='/topic/show?id=7e5a492636a' target=_blank style='color:#2F92EE;'>#应对策略#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49263, encryptionId=7e5a492636a, topicName=应对策略)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Tue Feb 10 17:52:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]
    2015-04-17 howi
  5. [GetPortalCommentsPageByObjectIdResponse(id=1791896, encodeId=71621e91896e6, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Mar 26 10:52:00 CST 2015, time=2015-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1985826, encodeId=19cf1985826e8, content=<a href='/topic/show?id=d3de559667c' target=_blank style='color:#2F92EE;'>#护理人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55966, encryptionId=d3de559667c, topicName=护理人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Jun 26 10:52:00 CST 2015, time=2015-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26972, encodeId=97d4269e2d1, content=mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=761999770, createdName=wingjoy2009, createdTime=Thu Jun 11 07:41:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827931, encodeId=da82182e9313c, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Apr 17 07:52:00 CST 2015, time=2015-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1836091, encodeId=c28e1836091b9, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Tue Jan 06 11:52:00 CST 2015, time=2015-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992243, encodeId=8390199224388, content=<a href='/topic/show?id=7e5a492636a' target=_blank style='color:#2F92EE;'>#应对策略#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49263, encryptionId=7e5a492636a, topicName=应对策略)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Tue Feb 10 17:52:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]
    2015-01-06 Boyinsh
  6. [GetPortalCommentsPageByObjectIdResponse(id=1791896, encodeId=71621e91896e6, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Mar 26 10:52:00 CST 2015, time=2015-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1985826, encodeId=19cf1985826e8, content=<a href='/topic/show?id=d3de559667c' target=_blank style='color:#2F92EE;'>#护理人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55966, encryptionId=d3de559667c, topicName=护理人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Jun 26 10:52:00 CST 2015, time=2015-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26972, encodeId=97d4269e2d1, content=mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=761999770, createdName=wingjoy2009, createdTime=Thu Jun 11 07:41:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827931, encodeId=da82182e9313c, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Apr 17 07:52:00 CST 2015, time=2015-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1836091, encodeId=c28e1836091b9, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Tue Jan 06 11:52:00 CST 2015, time=2015-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992243, encodeId=8390199224388, content=<a href='/topic/show?id=7e5a492636a' target=_blank style='color:#2F92EE;'>#应对策略#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49263, encryptionId=7e5a492636a, topicName=应对策略)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Tue Feb 10 17:52:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]

相关资讯

Lancet Neurol:简单可靠的老年痴呆症诊断标准

阿尔茨海默氏病(Alzheimer's disease,老年痴呆症)是一种神经退行性疾病,是痴呆最常见的一种类型(70%)。在法国,患有老年痴呆症和其他形式痴呆的人数估计在75万和100万之间,到2030年预计将达到129万到140万之间。老年痴呆症起因于神经元的损失。病变是由一些大脑蛋白的积累引起。病理学始于记忆问题。紧随其后的是时间和空间上的定位问题、行为问题和自主性丧失。然而,这些症状并不是

PLoS One:糖尿病或是老年痴呆症独立危险因素

来自我国台湾的一项人群队列研究提示,糖尿病与阿尔茨海默病(俗称老年痴呆症)风险增加有关,但应用降糖药物并不能降低糖尿病患者的老年痴呆症风险。 【原文下载】 Figure 2. The trend of the incidence of Alzheimer’s disease (AD) according to the duration of diabetes mel

PLoS One:抗血栓药有助缓解老年痴呆症

近日,来自日本国立循环器官疾病研究中心的研究人员调查发现,抗血栓药物西洛他唑(Cilostazol)还具有缓解老年痴呆症的作用。他们将这一发现在线刊登在了近期的《PLOS ONE》期刊上。 西洛他唑是一种用于预防脑梗塞复发的药物,可抑制血小板聚集,扩张血管,改善脑内血流,从而预防血栓形成。老年痴呆症是脑内血管和神经细胞出现障碍,导致记忆力等认知能力下降造成的。 由于很多老年痴呆症患者都并发血管

PLOS ONE:绿茶有助预防老年痴呆症

日本一个研究小组最新研究发现,绿茶具有预防老年痴呆症的作用,习惯每天喝绿茶的人,患病率大约只有不喝绿茶人的三分之一。 从2007年到2013年,日本金泽大学研究人员以石川县的490名60岁以上的居民为对象,调查了老年痴呆症的发病率。结果发现,在完全没有饮用绿茶习惯的138人中,有43人患上老年痴呆症或者轻度认知障碍;而每天饮用绿茶的157人中,只有18人患病。另外还发现,隔三差五喝绿茶的人患病风险

STM:老年痴呆症诊断标志物水平随病程发展而变化

目前,三个正在被研究的有前途的生物标志物(用于在疾病早期阶段检测老年痴呆症),似乎要经历一个令人惊讶的转变。华盛顿大学医学院科学家使用生物标记物来评估研究志愿者疾病相关的大脑变化。在老年痴呆症发病前,脊髓液中神经元损伤标志物的水平增加了十倍或更多,但出现了一个新的转折,研究第一次表明,随着记忆丧失和精神症状下降的出现,标志物水平后期会出现逆反下降过程。相关研究发表在Scie

Nat Med:血检测早期痴呆准确率90%

据英国《卫报》网站3月9日报道,研究称,血液可以预测人是否会在接下来三年内患阿尔茨海默症(老年痴呆症AD),其准确率高达90%。 研究人员发现,血液的变化有可能是老年痴呆症的早期反映。一项发表在《自然医学》杂志上的研究指出:血液中有10个分子可以用来预测人们是否会在近年内出现轻度认知障碍(MCI)或者老年痴呆症。 这是第一个能够在早期血液中发现患有老年痴呆症生物标志的研